Afya Limited (NASDAQ:AFYA – Get Free Report) shares reached a new 52-week low during trading on Tuesday . The company traded as low as $15.00 and last traded at $15.08, with a volume of 33547 shares traded. The stock had previously closed at $15.33.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on AFYA shares. UBS Group started coverage on Afya in a research note on Friday, August 30th. They set a “neutral” rating and a $19.50 target price for the company. The Goldman Sachs Group assumed coverage on Afya in a research report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 target price for the company.
Check Out Our Latest Stock Analysis on Afya
Afya Stock Up 1.0 %
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Lifestyle Asset Management Inc. lifted its holdings in shares of Afya by 13.3% during the third quarter. Lifestyle Asset Management Inc. now owns 16,753 shares of the company’s stock worth $286,000 after buying an additional 1,969 shares during the last quarter. Public Employees Retirement System of Ohio acquired a new stake in Afya during the third quarter worth about $34,000. Quarry LP bought a new position in Afya during the third quarter valued at about $75,000. Quantbot Technologies LP raised its holdings in Afya by 73.8% in the 3rd quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock valued at $226,000 after acquiring an additional 5,636 shares in the last quarter. Finally, Centiva Capital LP bought a new stake in shares of Afya in the 3rd quarter worth approximately $213,000. 88.02% of the stock is owned by institutional investors.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
See Also
- Five stocks we like better than Afya
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What Investors Need to Know About Upcoming IPOs
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
- What Are Earnings Reports?
- Rebalancing in 2025: Here Are 3 Stocks to Buy Under $10
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.